This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 4 EPO patents. Top assignee: Shire Biochem, Inc.. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: The Innovations of Robert Paul Haslam
Introduction
Robert Paul Haslam is an accomplished inventor based in Pewsey, GB. He is known for his significant contributions to the field of pharmaceuticals, particularly through his innovative formulations involving lanthanum compounds. With a focus on creating effective and chewable pharmaceutical products, Haslam has made strides in improving patient compliance and medication delivery.
Latest Patents
Haslam holds a patent for a pharmaceutical formulation comprising lanthanum compounds. This invention relates to a chewable lanthanum formulation that includes a pharmaceutically effective amount of a lanthanum compound and at least one chewable pharmaceutically acceptable excipient. The patent also covers a pharmaceutical formulation in tablet or powder form, produced through a specific process that involves powder blending, compressing, and milling to create a free-flowing mixture. This innovative approach aims to enhance the usability and effectiveness of lanthanum-based medications.
Career Highlights
Throughout his career, Haslam has worked with notable companies in the pharmaceutical industry, including Shire Biochem, Inc. and Shire Holdings AG. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical formulations, contributing to advancements in medication delivery systems.
Collaborations
Haslam has collaborated with several professionals in his field, including Laura Anna Trespidi and Josephine Christine Ferdinando. These collaborations have likely enriched his work and contributed to the success of his innovative projects.
Conclusion
Robert Paul Haslam's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the field. His patent for a chewable lanthanum formulation highlights his ability to address patient needs effectively. Through his work and collaborations, Haslam continues to make a significant impact in the pharmaceutical industry.